Spanish health authorities have issued an urgent alert regarding a specific batch of a popular hair dye product, prompting immediate action from consumers and retailers nationwide. The Spanish Agency of Medicines and Medical Devices (AEMPS) announced on Thursday, April 24, 2025, the cessation of sales, market withdrawal, and product recall for all batches of the hair dye marketed under the name “Blonde…” following safety concerns identified during routine monitoring.
The AEMPS, operating as Spain’s highest sanitary authority for medicines and health products under the Ministry of Health, stated that the decision was made after detecting non-compliance with safety standards during pharmacovigilance activities. While the agency did not specify the exact nature of the risk in its initial announcement, such actions typically stem from potential health hazards like skin sensitization, allergic reactions, or contamination discovered post-market. The alert applies uniformly across all production lots of the product, indicating a broad safety concern rather than an isolated manufacturing issue.
This regulatory intervention underscores the AEMPS’s ongoing responsibility to oversee the safety of cosmetic products available to Spanish consumers, a mandate expanded under national legislation since the agency’s formation in 1997. The authority collaborates closely with the European Medicines Agency (EMA) and other EU member states through coordinated procedures to ensure consistent safety evaluations across borders, particularly for products distributed in multiple countries.
Consumers who have purchased the affected hair dye are advised to discontinue use immediately and return the product to the point of purchase for a full refund, regardless of whether they have experienced adverse effects. Retailers have been instructed to remove all stock from shelves and quarantine the items pending further instructions from the AEMPS. The agency emphasized that individuals experiencing any unusual symptoms after use—such as redness, itching, swelling, or blistering—should seek medical attention promptly and report the incident through Spain’s official cosmetic vigilance system.
The AEMPS maintains a publicly accessible database where safety alerts and product recalls are published in real time, allowing both healthcare professionals and the public to verify the status of health products. This particular alert is part of the agency’s broader surveillance framework, which includes monitoring adverse reaction reports, conducting factory inspections, and reviewing product dossiers before and after authorization. In 2023, the AEMPS managed an annual budget of €85.5 million and employed 524 staff to carry out these regulatory functions across medicines, medical devices, cosmetics, and personal care products.
As of the announcement date, no further details regarding the specific chemical concern, geographic distribution beyond Spain, or timeline for resolution had been released by the AEMPS. The agency confirmed that investigations are ongoing and that additional updates will be provided as safety assessments progress. Stakeholders are directed to the AEMPS’s official website and press office for verified information, avoiding reliance on unverified claims circulating through unofficial channels.
This incident highlights the critical role of post-market surveillance in consumer protection, demonstrating how regulatory systems can respond swiftly to emerging safety signals even after products have been widely distributed. For individuals using hair dyes or similar cosmetic products, health experts recommend performing patch tests prior to full application and maintaining awareness of product recall notices through official national health agency communications.
The next official update from the AEMPS regarding this specific product recall is expected within the standard regulatory timeframe for such safety communications, though no exact date has been specified in the current alert. Consumers and industry stakeholders are encouraged to consult the AEMPS’s dedicated section on cosmetic product safety for the most accurate and timely developments.
Have you encountered this product recall or have experience with cosmetic safety alerts? Share your insights in the comments below to help inform others, and consider sharing this article to spread awareness about crucial health and safety updates.